SINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
SHOULDER INNOVATIONS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$18.25+0.16 (+0.88%)
Close on Oct 19, 2026
- Market cap
- $378.43M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$5.75 (+46.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
SHOULDER INNOVATIONS, INC. grew revenue 60.9% to $60.06M over the twelve months to Jun 30, 2026. Free cash flow was -$47.08M.
Revenue
$60.06M
+60.9% vs. a year earlier
Operating income
-$35.15M
TTM Q2 2026
Free cash flow
-$47.08M
TTM Q2 2026
EPS, diluted
-$4.65
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $378.43M
- P/E ratio
- –
- Price to sales
- 6.30
- Price to book
- 3.04
- Dividend yield
- –
- Free cash flow yield
- -12.44%
Fundamentals
- Revenue
- $60.06M
- Net income
- -$35.03M
- EPS, diluted
- -$4.65
- Free cash flow
- -$47.08M
- Book value per share
- $6.00
- Diluted shares
- 21M
Three years at a glance
Fiscal years 2023 to 2025 and trailing twelve months, USD
Revenue
$60.06M+60.9% YoY
Gross profit
$46.45M+62.1% YoY
Operating income
-$35.15M
Net income
-$35.03M
EPS, diluted
–
Free cash flow
-$47.08M
Reported periodTrailing twelve months